Form 4 for CELU Celularity Inc
Accepted 2021-12-02 00:00:00 ET · period of report 2021-11-09 · accession 0000899243-21-046680 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-02 | 2021-11-09 | CELU | VON ESCHENBACH ANDREW C. | Dir | M - OptEx | $0.28 | +100.0K | 100.0K | New | +$28.0K |
| D | 2021-12-02 | 2021-11-09 | CELU | VON ESCHENBACH ANDREW C. | Dir | M - OptEx | $0.00 | -100.0K | 207.4K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-11-09 | M | A | 100,000 | $0.28 | 100,000 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-11-09 | M | D | 100,000 | $0.00 | 207,437 | D | $0.28 · — to 2027-06-02 | 100,000 Class A Common Stock | (F1) This option is fully vested and exercisable. |